Want to join the conversation?
Drugmaker $ABBV reported a rise in 1Q16 earnings on higher revenue backed by continued momentum across rheumatology, dermatology and gastroenterology markets. Net income rose to $1.35Bil or $0.83 per share from $1.02Bil or $0.63 per share last year. Net revenues grew to $5.96Bil from $5.04Bil. Adjusted EPS increased to $1.15 from $0.94.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.